BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND WIF1, WIF-1, 11197, ENSG00000156076
13 results:

  • 1. Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway.
    Ma Y; Li Y; Huang M; Meng Y
    J Chemother; 2023 May; 35(3):240-249. PubMed ID: 35666085
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Gene Methylation and Silencing of wif1 Is a Frequent Genetic Abnormality in Mantle Cell lymphoma.
    Alshareef A; Peters AC; Gélébart P; Chen W; Lai R
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477402
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options.
    van Andel H; Kocemba KA; Spaargaren M; Pals ST
    Leukemia; 2019 May; 33(5):1063-1075. PubMed ID: 30770859
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia.
    Lyu X; Li J; Yun X; Huang R; Deng X; Wang Y; Chen Y; Xiao G
    Oncol Rep; 2017 Mar; 37(3):1469-1476. PubMed ID: 28184923
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Expression of wif-1 and β-catenin in the Wnt pathway in childhood acute lympho-blastic leukemia].
    Gao JZ; Zhao JO; Tan Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Sep; 18(9):835-839. PubMed ID: 27655540
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.
    Kristensen IB; Christensen JH; Lyng MB; Møller MB; Pedersen L; Rasmussen LM; Ditzel HJ; Abildgaard N
    Leuk Lymphoma; 2014 Apr; 55(4):911-9. PubMed ID: 23915193
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Black raspberry-derived anthocyanins demethylate tumor suppressor genes through the inhibition of DNMT1 and DNMT3B in colon cancer cells.
    Wang LS; Kuo CT; Cho SJ; Seguin C; Siddiqui J; Stoner K; Weng YI; Huang TH; Tichelaar J; Yearsley M; Stoner GD; Huang YW
    Nutr Cancer; 2013; 65(1):118-25. PubMed ID: 23368921
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic heterogeneity of diffuse large B-cell lymphoma.
    Zhang J; Grubor V; Love CL; Banerjee A; Richards KL; Mieczkowski PA; Dunphy C; Choi W; Au WY; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers C; Naresh K; Evens A; Gordon LI; Czader M; Gill JI; Hsi ED; Liu Q; Fan A; Walsh K; Jima D; Smith LL; Johnson AJ; Byrd JC; Luftig MA; Ni T; Zhu J; Chadburn A; Levy S; Dunson D; Dave SS
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1398-403. PubMed ID: 23292937
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
    Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
    Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma.
    Litvinov IV; Jones DA; Sasseville D; Kupper TS
    Clin Cancer Res; 2010 Apr; 16(7):2106-14. PubMed ID: 20233883
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemia.
    Martin V; Agirre X; Jiménez-Velasco A; José-Eneriz ES; Cordeu L; Gárate L; Vilas-Zornoza A; Castillejo JA; Heiniger A; Prósper F; Torres A; Roman-Gomez J
    Cancer Sci; 2008 Sep; 99(9):1865-8. PubMed ID: 18549404
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.
    Román-Gómez J; Cordeu L; Agirre X; Jiménez-Velasco A; San José-Eneriz E; Garate L; Calasanz MJ; Heiniger A; Torres A; Prosper F
    Blood; 2007 Apr; 109(8):3462-9. PubMed ID: 17148581
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
    J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.